{
    "nctId": "NCT03476070",
    "briefTitle": "Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)",
    "officialTitle": "Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Lymphoma, Germ Cell Tumor, Cognitive Impairment",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 236,
    "primaryOutcomeMeasure": "Prevalence of cognitive impairment in AYA cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* between 15-39 years of age\n* newly diagnosed with breast cancer, lymphoma or germ cell tumor with treatment intent determined as curative by medical oncologist\n* scheduled for chemotherapy with or without non-cranial radiotherapy\n* no prior history of chemotherapy and/or radiotherapy\n* able to read and understand English\n* capable of giving informed consent (or obtaining parents' consent if required)\n\nExclusion Criteria:\n\n* physically or mentally incapable of providing verbal/written consent\n* diagnosed with primary or metastatic brain tumor(s) or relapsed disease\n* treatment includes intrathecal or intraventricular chemotherapy\n* evidence of psychosis or underlying neuropsychiatric illness that may impair cognitive abilities\n* have immediate family member who is enrolled as in the healthy control arm\n* any contraindication to MRI as stated in the study protocol including: pregnancy, metal fragments/implants in body, known claustrophobia, and non-removable metal orthodontic braces, metallic retainers and oral wires",
    "sex": "ALL",
    "minimumAge": "15 Years",
    "stdAges": "CHILD, ADULT"
}